Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: Understanding clinical trial results

  1. Ocaña, A.
  2. Amir, E.
  3. Pandiella, A.
Journal:
Oncotarget

ISSN: 1949-2553

Year of publication: 2018

Volume: 9

Issue: 61

Pages: 31915-31919

Type: Review

DOI: 10.18632/ONCOTARGET.25739 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus